Find latest AML videos · 300+ videos
University of Miami Sylvester Comprehensive Cancer Center
S

Role of Mutations in AML: FLT3-ITD Mutation Confers Poor Prognosis but is Actionable

By University of Miami Sylvester Comprehensive Cancer Center FEATURING Sangeetha Venugopal
By University of Miami Sylvester Comprehensive Cancer Center FEATURING Sangeetha Venugopal
192 views
March 18, 2024
Comments 1
Login to view comments. Click here to Login

Related Videos

25:03

ASH 2024 Summary: Highlights in AML, MDS, and ALL

2024 ASH Annual Meeting Insights Hub

T. Badar

1.2K views
19:01

Debates in AML: 7+3 Is No Longer the Standard of Care

XV Eurasian Hematology-Oncology Congress - EHOC 2024

T. Kadia

1.1K views
12:55

ASH 2024 Summary: Menin Inhibitors in AML - FDA Approval and Highlig…

2024 ASH Annual Meeting Insights Hub

J. Zeidner

434 views
21:24

ASH 2024 Insights: Venetoclax + Aza for 1L Younger AML Pts Independe…

2024 ASH Annual Meeting Insights Hub

J. Watts

343 views
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

4.7K views
15:16

ASH 2024 Summary: Transplant Options and Outcomes for TP53 Myeloid D…

2024 ASH Annual Meeting Insights Hub

H. Fernandez

253 views
21:51

Experts Discuss the Pathophysiology, Diagnosis, and Treatment of BPD…

MyCancerHaven

R. Vij, G. Murthy

698 views
27:49

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

822 views
25:44

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

378 views
35:03

Advancements in AML Management in 2024

Louisville Hematology Highlights

C. Lachowiez

202 views
19:10

Steroid-Refractory GVHD Updates

Roswell Park Comprehensive Cancer Center

S. Holtan

192 views
19:21

Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde

SOHO Brazil 2024

J. Lancet

594 views
14:25

New

Revumenib for KMT2A+ R/R Acute Leukemias - Drug Overview and Clinica…

OncoPharm

J. Bossaer

18 views
27:26

Where I Use Azacitidine and Venetoclax in AML: Present and Future

SOHO Brazil 2024

J. Lancet

528 views
07:37

New

Tandem 2025 Insights: PTCy-Based GVHD Prophylaxis After Mismatched U…

Insights from 2025 Tandem Annual Meeting

M. Al Malki

128 views
07:10

New

Long-Term Follow-Up of the VIALE-A Study: Survival Outcomes and Subg…

Walter Fiedler

106 views
05:07

ASH 2024 Insights: Clinical Study of Oral Azacitidine and Venetoclax…

2024 ASH Annual Meeting Insights Hub

M. Amaya

125 views
26:58

New

Understanding the AML Disease State: Key Challenges and Advances

Cleveland Clinic Taussig Cancer Institute

M. Mustafa Ali

91 views
17:51

Treatment of AML: Managing the Patient When Transplant Is Not an Opt…

Indy Hematology Review

H. Erba

965 views
24:06

New

ASH 2025 Review: FLT3 Inhibitors in AML - Updates and Comparative In…

University of Colorado Division of Hematology

M. Angelos

63 views
AUTOPLAY